All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
NAMs Technology Partn3Ring webinar
April 22 @ 2:00 pm - 3:15 pm
The first NAMs webinar will include presentations from researchers working across invertebrate models as partial replacements for the use of mammals, human-relevant microphysiological models, drug efficacy and drug/consumer product toxicity testing.
Early drug screening with C. elegans: A 3Rs-aligned approach
Sara Leighton (Magnitude Biosciences Limited)
• High-throughput C. elegans platform, delivering scalable and predictive insights on drug efficacy, safety and mechanism of action.
• Seeking collaborators to further qualify screening platform and provide access to comparator datasets.
From model to method: Validating C. elegans-based DART assay towards regulatory use
Eva Martini (Nagi Bioscience)
• Providing human relevant whole organism toxicity data that can replace early mammalian screens.
• Seeking collaborators for new toxicology use cases, cross‑species comparison, and standardisation towards regulatory readiness.
Title TBC
Margaret Magdesian (Ananda Devices)
• Developing human iPSC‑based neuro and neuromuscular assays towards replacing animal use in neurotoxicity assays.
• Seeking partners to benchmark and expand applications, including exploring incorporation into regulatory workflows.
Title TBC
Vitaliy Khutoryanskiy (University of Reading)
• Developing invertebrate assays that can replace early-stage mammalian studies in toxicity, irritation, infection and formulation screening.
• Seeking collaborators interested in co-developing and qualifying the invertebrate-based assays for broader application and increased translational relevance.
Register
